Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study

Novel COVID-19 is a highly infectious disease that is caused by the recently discovered SARS-CoV-2. It is a fast-spreading disease that urgently requires therapeutics. The current study employed computational regression methods to target the ADP-ribose phosphatase (ADRP) domain of Nsp3 using FDA-app...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Ajita, Sharma, Mohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285112/
https://www.ncbi.nlm.nih.gov/pubmed/34290823
http://dx.doi.org/10.2217/fvl-2020-0361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285112/
https://www.ncbi.nlm.nih.gov/pubmed/34290823
http://dx.doi.org/10.2217/fvl-2020-0361

Ejemplares similares